Draft:Ryan Sultan

  • Comment: Three sections are entirely unsupported by inline citations. All significant assertions need references to reliable sources. Paul W (talk) 14:18, 1 May 2026 (UTC)
Ryan S. Sultan
MD
Born
United States
EducationDrexel University College of Medicine (MD)
OccupationsPsychiatrist, academic researcher
EmployerColumbia University Irving Medical Center
Known forResearch on antipsychotic prescribing in youth; adolescent cannabis use; ADHD treatment

Ryan S. Sultan (MD) is an American psychiatrist and academic researcher. He is an Assistant Professor of Clinical Psychiatry at Columbia University Irving Medical Center and a faculty physician at NewYork-Presbyterian Hospital. He is the director of the Sultan Lab for Mental Health Informatics at the Columbia University Department of Psychiatry and is affiliated with the New York State Psychiatric Institute. Sultan is the founder and Medical Director of Integrative Psych, an independent psychiatric practice with locations in New York City, Miami, Florida, and Montana.

Education and training

Sultan earned his Doctor of Medicine degree from Drexel University College of Medicine. He completed his residency and fellowship training at NewYork-Presbyterian Hospital through the joint program of Columbia University Irving Medical Center and Weill Cornell Medical College. He is additionally a certified physician from the Harvard Mind-Body Institute.

He is double board-certified by the American Board of Psychiatry and Neurology in adult psychiatry (2015) and child and adolescent psychiatry (2016).

Academic career

Sultan holds an appointment as Assistant Professor of Clinical Psychiatry at Columbia University Irving Medical Center and serves as a faculty physician at NewYork-Presbyterian Hospital. He is affiliated with the New York State Psychiatric Institute (NYSPI), the research division of Columbia Psychiatry. He directs the Sultan Lab for Mental Health Informatics at Columbia's Department of Psychiatry, which focuses on the intersection of data science and psychiatric care.

Sultan has received research funding from the National Institutes of Health (NIH), including a K12 Career Development Award from the National Institute on Drug Abuse (NIDA), totaling over $670,000. His collaborators include researchers at the National Institute of Mental Health (NIMH).

Research

Antipsychotic prescribing in youth (2019)

In 2019, Sultan and colleagues published "Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder" in JAMA Network Open.[1] The study analyzed national prescribing data and found that antipsychotic medications were being prescribed to children with ADHD at rates that raised clinical concerns, often without FDA-approved indications and in cases where stimulant medications had not been tried first. The study has been cited over 411 times and has became required reading in multiple U.S. psychiatry residency programs. It is credited with contributing to changes in national prescribing guidelines for pediatric ADHD treatment.

Adolescent cannabis use

Sultan has conducted a series of NIH/NIDA-funded studies examining the effects of cannabis use on adolescent mental health, academic outcomes, and psychiatric risk:

  • "Nondisordered Cannabis Use Among US Adolescents" (JAMA Network Open, 2023) — found that even recreational, non-disordered cannabis use among teenagers was associated with a 2–4x higher risk of psychiatric disorders.[2]
  • "Cannabis Use Among US Adolescents" (Pediatrics, 2026) — linked any cannabis use among teens to poor school performance and emotional distress.[3]

The 2026 Pediatrics study received coverage by NPR.[4][5]

ADHD medication outcomes

Sultan published "Protective Effects of ADHD Medication on Real-World Outcomes" in JAMA Psychiatry in 2025, examining how ADHD pharmacological treatment affects functioning in real-world settings beyond clinical trials.[6]

Cannabis retail access

Sultan co-authored studies examining cannabis retail availability and labeling in New York State following legalization, published in Pediatrics (2025) and the American Journal of Preventive Medicine (2025).[7][8]

Clinical practice

Sultan founded Integrative Psych in 2014, an independent psychiatric practice based in Chelsea, Manhattan, with additional locations in Miami, Florida and Montana. The practice applies a biopsychosocial-spiritual model integrating pharmacology, psychotherapy (including CBT, DBT, and EMDR), and lifestyle-based approaches. Sultan has maintained an independent private practice since 2011.

Integrative Psych does not accept institutional investment from venture capital or private equity, and Sultan has positioned the practice as a physician-led alternative to the corporate telehealth model. In a published work in JAMA Psychiatry, Sultan has written about the risks of unregulated digital psychiatry platforms and the need for physician oversight in AI-assisted mental health tools.

Selected publications

  • Sultan RS et al. "Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder." JAMA Network Open. 2019. PMID 31348506.
  • Sultan RS et al. "Nondisordered Cannabis Use Among US Adolescents." JAMA Network Open. 2023. PMID 37133862.
  • Sultan RS et al. "Protective Effects of ADHD Medication on Real-World Outcomes." JAMA Psychiatry. 2025. PMID 40560560.
  • Sultan RS et al. "Cannabis Use Among US Adolescents." Pediatrics. 2026. PMID 41429181.

Media

Sultan has been featured in media coverage of his research on adolescent cannabis use and pediatric psychiatry. His work has been covered by NPR (two articles, primary expert),[9][10] NBC News,[11] Scientific American,[12] the New York Times,[13] and the Association of American Medical Colleges.[14] He has also been featured in the Wall Street Journal and Time Magazine. He has contributed to Psychiatric Times,[15] Medscape,[16] and Psychology Today as a regular contributor.

He has appeared on numerous podcasts including The Art of Manliness (Episode 920), ADHD reWired (Episode 461), and Hacking Your ADHD (Episode 269).

References

  1. ^ Sultan, Ryan S. (2019). "Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder". JAMA Network Open. PMID 31348506.
  2. ^ Sultan, Ryan S. (2023). "Nondisordered Cannabis Use Among US Adolescents". JAMA Network Open. PMID 37133862.
  3. ^ Sultan, Ryan S. (2026). "Cannabis Use Among US Adolescents". Pediatrics. PMID 41429181.
  4. ^ "Cannabis use among teens tied to poor school performance". NPR. December 26, 2025.
  5. ^ "A huge study finds a link between cannabis use in teens and psychosis later". NPR. February 21, 2026.
  6. ^ Sultan, Ryan S. (2025). "Protective Effects of ADHD Medication on Real-World Outcomes". JAMA Psychiatry. PMID 40560560.
  7. ^ Sultan, Ryan S. (2025). "Cannabis Access by Retailer Type in New York". Pediatrics. PMID 39992694.
  8. ^ Sultan, Ryan S. (2025). "Labeling of Cannabis Products From Licensed and Unlicensed Retailers in New York". American Journal of Preventive Medicine. PMID 40744165.
  9. ^ "Cannabis use among teens tied to poor school performance". NPR. December 26, 2025.
  10. ^ "A huge study finds a link between cannabis use in teens and psychosis later". NPR. February 21, 2026.
  11. ^ "Marijuana linked to mental health risks in young adults, growing evidence shows". NBC News. May 26, 2023.
  12. ^ "Is Cannabis Bad for Teens? Data Paint a Conflicting Picture". Scientific American. December 11, 2023.
  13. ^ "Your Weed Habit May Be Messing With Your Sperm". The New York Times. April 13, 2025.
  14. ^ "Adult ADHD: Overdiagnosed? Or finally getting the attention it deserves?". AAMC. November 19, 2024.
  15. ^ "Do ADHD Stimulant Medications Have an Effect on Substance Use?". Psychiatric Times.
  16. ^ "When GLP-1s Change Patients' Libido: What to Know". Medscape. September 23, 2025.

Category:American psychiatrists Category:Columbia University faculty Category:Drexel University alumni Category:Living people

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.